Cardiopulmonary Risk Evaluation Study

Now Enrolling Adults Ages 40 to 80

● Now Enrolling

About this research study

Velocity is enrolling adults with COPD and cardiopulmonary risk factors, or at high risk of developing cardiopulmonary disease risk factors for a research study evaluating severe cardiac and pulmonary outcomes

This study will evaluate the effect of triple ICS/LAMA/LABA inhalers in comparison to LAMA/LABA inhalers on cardiopulmonary outcomes in participants with cardiopulmonary risk.

Eligible participants...

Must be age 40 to 80 years
Must have COPD and
- A Combination of any of the following cardiovascular disease risk factors: hypertension, diabetes mellitus, chronic kidney disease, dyslipidemia, obesity.
- High risk of cardiovascular disease
- Documented historical CT coronary artery calcification
Established CV disease (Myocardial infarction, heart failure, Peripheral arterial disease, angina pectoris…)
Must NOT have an active diagnosis of asthma, asthma-COPD, or any other chronic respiratory disease other than COPD within the past 5 years
Must not be using inhaled corticosteroids therapy
May receive compensation for study-related time
Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

This field is for validation purposes and should be left unchanged.

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Anderson, South Carolina • Velocity Clinical Research

1214 N. Fant Street, Anderson, SC 29621
Phone: (864) 965-0190

San Bernardino, California • Velocity Clinical Research

650 E. Hospitality Lane, Suite 200, San Bernardino, CA 92408
Phone: (951) 755-0222

Gaffney, South Carolina • Velocity Clinical Research

1529 N. Limestone Street, Gaffney, SC 29340
Phone: (864) 488-1283

Gardena, California • Velocity Clinical Research

1141 W. Redondo Beach Blvd., Suite 308, Gardena, CA 90247
Phone: (424) 551-7316

Grand Island, Nebraska • Velocity Clinical Research

711 N. Custer Ave., Suite B, Grand Island, NE 68803
Phone: (308) 365-8900

Gulfport, Mississippi • Velocity Clinical Research

15444 Dedeaux Road, Suite B, Gulfport, MS 39503
Phone: (228) 206-1283

New Smyrna Beach (Edgewater), Florida • Velocity Clinical Research

1410 S. Ridgewood Avenue, Edgewater, FL 32132
Phone: (386) 428-7730

Van Nuys, California • Velocity Clinical Research

15211 Vanowen Street, Suite 100, Van Nuys, CA 91405
Phone: (818) 532-6880

Phoenix, Arizona • Velocity Clinical Research

555 N. 18th Street, Suite 100, Phoenix, AZ 85006
Phone: (602) 368-1928

Rockville, Maryland • Velocity Clinical Research

1201 Seven Locks Road, Suite 214, Rockville, MD 20854
Phone: (240) 698-2800

Salt Lake City (West Jordan), Utah • Velocity Clinical Research

3590 West 9000 South, Suite 300, West Jordan, UT 84088
Phone: (801) 542-8190

San Diego, California • Velocity Clinical Research

8881 Fletcher Parkway, Suite 300, San Diego, CA, 91942
Phone: (619) 567-1550

Sioux City, Iowa • Velocity Clinical Research

4802 Sunnybrook Drive, Sioux City, IA 51106
Phone: (712) 639-6300

Spartanburg, South Carolina • Velocity Clinical Research

141 Harold Fleming Court, Spartanburg, SC 29303
Phone: (864) 515-0092

Union, South Carolina • Velocity Clinical Research

1005 Thompson Blvd, Union, SC 29379
Phone: (864) 427-1172

Valparaiso, Indiana • Velocity Clinical Research

55 University Drive, Suite 106, Valparaiso, IN 46383
Phone: (219) 464-8302

Washington, District of Columbia • Velocity Clinical Research

4910 Massachusetts Ave NW, Ste 315, Washington, DC 20016
Phone: (202) 998-3833

Medford, Oregon • Velocity Clinical Research

3121 Signature Court, Medford, OR 97504
Phone: (541) 858-1018